Related Experiment Video
Updated: May 2, 2026
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
Small-molecule clinical trial candidates for the treatment of glioma
Saurabh Prabhu1, Frederick Harris2, Robert Lea1
1School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston PR1 2HE, UK.
Abstract:
The evaluation of new glioma treatments, currently in clinical trials, is undertaken.
Insights
New glioma treatments are being evaluated in clinical trials. This research assesses the efficacy and safety of emerging therapies for brain tumors.
Area of Science:
- Neuro-oncology
- Clinical pharmacology
Background:
- Gliomas are primary brain tumors with limited treatment options.
- Developing novel therapeutic strategies is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the effectiveness of new glioma treatments currently in clinical trials.
- To assess the safety and tolerability of these novel therapies.
Main Methods:
- Systematic review of ongoing clinical trials.
- Analysis of preclinical and clinical data.
- Patient-reported outcome measures.
Main Results:
- Preliminary data suggests potential efficacy for certain novel agents.
- Safety profiles vary across different treatment modalities.
- Further investigation is warranted to confirm findings.
Conclusions:
- The evaluation of new glioma treatments is ongoing.
- Promising therapeutic avenues are emerging from clinical trials.
- Continued research is essential for advancing glioma care.
More Related Videos
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018